Back
Antero Midstream 10K Form
Buy
67
AM
Antero Midstream
Last Price:
15.87
Seasonality Move:
4.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-24 | 10Q | AM/Antero Midstream Quarterly |
| 2023-10-25 | 10Q | AM/Antero Midstream Quarterly |
| 2023-07-26 | 10Q | AM/Antero Midstream Quarterly |
| 2023-04-26 | 10Q | AM/Antero Midstream Quarterly |
| 2022-10-26 | 10Q | AM/Antero Midstream Quarterly |
| 2022-07-27 | 10Q | AM/Antero Midstream Quarterly |
Receive AM News And Ratings
See the #1 stock for the next 7 days that we like better than AM
AM Financial Statistics
Sales & Book Value
| Annual Sales: | $1.11B |
|---|---|
| Cash Flow: | $130.04M |
| Price / Cash Flow: | 13.52 |
| Annual Sales: | $4.43 |
| Price / Book: | 3.54 |
Profitability
| EPS (TTM): | 0.80000 |
|---|---|
| Net Income (TTM): | $390.15M |
| Gross Margin: | $692.55M |
| Return on Equity: | 18.21% |
| Return on Assets: | 6.77% |
Antero Midstream Earnings Forecast
Key Antero Midstream Financial Ratios
- The Gross Profit Margin over the past 18 years for AM is 62.25%.
- The Selling, General & Administrative Expenses for AM have been equal to 6.39% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 58.43% of Operating Income.
- The Net Earning history of AM is 33.42% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 9 years.
Antero Midstream Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | AM |
| CUSIP: | 03673L |
| Website: | anteromidstream.com |
Debt
| Debt-to-Equity Ratio: | 1.49 |
|---|---|
| Current Ratio: | 1.09 |
| Quick Ratio: | 1.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.36 |
|---|---|
| Forward P/E Ratio: | 13.09 |
AM Technical Analysis vs Fundamental Analysis
Buy
67
Antero Midstream (AM)
is a Buy
Is Antero Midstream a Buy or a Sell?
-
Antero Midstream stock is rated a Buy
The current Antero Midstream [AM] share price is $15.68. The Score for AM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.